ModivCare (MODV)
(Delayed Data from NSDQ)
$26.04 USD
+0.71 (2.80%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $26.02 -0.02 (-0.08%) 7:58 PM ET
5-Strong Sell of 5 5
B Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.04 USD
+0.71 (2.80%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $26.02 -0.02 (-0.08%) 7:58 PM ET
5-Strong Sell of 5 5
B Value F Growth F Momentum D VGM
Zacks News
Medpace (MEDP) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 34.13% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ModivCare (MODV) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
ModivCare (MODV) delivered earnings and revenue surprises of 28.66% and 4.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareDx (CDNA) delivered earnings and revenue surprises of -250% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
ModivCare (MODV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
ModivCare (MODV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Q4 Earnings Beat Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 5.60% and 0.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: TimkenSteel, ModivCare, Capital Product Partners, Euroseas and DLH Holdings
by Zacks Equity Research
TimkenSteel, ModivCare, Capital Product Partners, Euroseas and DLH Holdings are highlighted in this screen of this week article.
Walgreens Boots (WBA) Q1 Earnings Top Estimates, 2022 View Up
by Zacks Equity Research
Walgreens Boots' (WBA) revenues increased year over year in the fiscal first quarter, driven by COVID-19 vaccinations and testing.
Solid Net Profit Margin Makes These 5 Stocks Worth Buying Now
by Anirudha Bhagat
Let's take a look at these five top-ranked stocks, TMST, MODV, CPLP, ESEA and DLHC, with impressive net profit margins for a winning portfolio.
MODV vs. AMEH: Which Stock Is the Better Value Option?
by Zacks Equity Research
MODV vs. AMEH: Which Stock Is the Better Value Option?
ModivCare (MODV) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
Walgreens (WBA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Faster adoption of digital health and recent partnerships are expected to have contributed to Walgreens' (WBA) first-quarter performance.
Zacks.com featured highlights include: Fidelity National Financial, ModivCare, Deutsche Post and TimkenSteel
by Zacks Equity Research
Zacks.com featured highlights include: Fidelity National Financial, ModivCare, Deutsche Post and TimkenSteel.
4 Stocks Riding High on Increasing Cash Flow to Buy Now
by Moumita C. Chattopadhyay
Analyzing a company's cash position can be rewarding because it reveals its true financial health. In this regard, stocks like Fidelity National Financial (FNF), ModivCare (MODV), Deutsche Post AG (DPSGY) and TimkenSteel (TMST) are worth buying.
Zacks.com featured highlights include: TimkenSteel, One Stop Systems, Fidelity National Title Group, Citi Trends and ModivCare
by Zacks Equity Research
Zacks.com featured highlights include: TimkenSteel, One Stop Systems, Fidelity National Title Group, Citi Trends and ModivCare
5 Stocks With Solid Net Profit Margin to Enrich Your Portfolio
by Anirudha Bhagat
Let's take a look at the five top-ranked stocks - TMST, OSS, FNF, CTRN and MODV - with stellar net profit margins for a winning portfolio.
MODV vs. GDRX: Which Stock Is the Better Value Option?
by Zacks Equity Research
MODV vs. GDRX: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: TimkenSteel, Deutsche Post, PDC Energy and ModivCare
by Zacks Equity Research
Zacks.com featured highlights include: TimkenSteel, Deutsche Post, PDC Energy and ModivCare
Scoop Up Big Gains With 4 Stocks Enjoying Rising Cash Flows
by Moumita C. Chattopadhyay
Cash is the most indispensable factor for any company. It provides strength and vitality to a company, as well as holds the key to its existence, development and success.
Zacks.com featured highlights include: TimkenSteel, Genco Shipping & Trading, PDC Energy, Capital Product Partners and ModivCare
by Zacks Equity Research
Zacks.com featured highlights include: TimkenSteel, Genco Shipping & Trading, PDC Energy, Capital Product Partners and ModivCare
5 Top-Ranked Stocks With Impressive Net Profit Margins
by Anirudha Bhagat
Let's take a look at the five buy-ranked stocks - TMST, GNK, PDCE, CPLP and MODV - with solid net profit margins for an enriching portfolio.
5 Finest Value Stocks Based on PEG Ratio
by Urmimala Biswas
Here are five value stocks, CAR, MODV, LNVGY, PAG and ATCO, which qualify the screening criteria.
MODV or AMEH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MODV vs. AMEH: Which Stock Is the Better Value Option?
Down 15.4% in 4 Weeks, Here's Why ModivCare (MODV) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for ModivCare (MODV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ModivCare (MODV) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
ModivCare (MODV) has been struggling lately, but the selling pressure may be coming to an end soon.
ModivCare (MODV) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
ModivCare (MODV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.